日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein.

通过靶向细胞表面 RNA 结合蛋白治疗急性髓系白血病模型。

George Benson M, Eleftheriou Maria, Yankova Eliza, Perr Jonathan, Chai Peiyuan, Nestola Gianluca, Almahayni Karim, Evans Siân, Damaskou Aristi, Hemberger Helena, Lebedenko Charlotta G, Rak Justyna, Yu Qi, Bapcum Ece, Russell James, Bagri Jaana, Volk Regan F, Spiekermann Malte, Stone Richard M, Giotopoulos George, Huntly Brian J P, Baxter Joanna, Camargo Fernando, Liu Jie, Zaro Balyn W, Vassiliou George S, Möckl Leonhard, de la Rosa Jorge, Flynn Ryan A, Tzelepis Konstantinos

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation

基线IPSS-M评分与移植前风险降期作为接受异基因移植的MDS患者的预后决定因素

Aguirre, Luis E; Kim, Haesook T; Elmariah, Hany; Frumm, Stacey M; Kelkar, Amar H; Ho, Vincent; Gooptu, Mahasweta; Koreth, John; Shapiro, Roman M; Romee, Rizwan; Nikiforow, Sarah; Antin, Joseph H; Soiffer, Robert J; Shimony, Shai; Luskin, Marlise R; Garcia, Jacqueline S; Chen, Evan C; Wadleigh, Martha; Winer, Eric S; Stone, Richard M; DeAngelo, Daniel J; Al Ali, Najla; Sallman, David; Kuykendall, Andrew; Sweet, Kendra; Lancet, Jeffrey E; Padron, Eric; Chan, Onyee; Xie, Zhuoer; Cutler, Corey S; Komrokji, Rami S; Stahl, Maximilian

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse

对于接受造血干细胞移植后急性髓系白血病复发并达到缓解的患者,细胞疗法巩固治疗并无明显益处

Murdock, H Moses; Kim, Haesook T; Maurer, Katie; Kelkar, Amar; Shapiro, Roman M; Gooptu, Mahasweta; Romee, Rizwan; Nageshwar, Prashant K; Garrity, Heather M; Shimony, Shai; Luskin, Marlise R; Winer, Eric S; Vedula, Rahul S; Stahl, Maximillian; Chen, Evan C; Volpe, Virginia; Garcia, Jacqueline S; Wadleigh, Martha; DeAngelo, Daniel J; Stone, Richard M; Wu, Catherine J; Cutler, Corey S; Koreth, John; Ritz, Jerome; Antin, Joseph H; Ho, Vincent T; Nikiforow, Sarah; Soiffer, Robert J

Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria

根据 ELN 2022 标准对生存率进行分层:社会健康决定因素对 AML 预后的影响

Shimony, Shai; Wang, Yating; Cronin, Angel; Walsh, Thomas P; Charles, Anne; Slopen, Natalie; Cho, Hae Lin; Stahl, Maximillian; Bystrom, Rebecca P; Luskin, Marlise R; Abel, Gregory A; DeAngelo, Daniel J; Stone, Richard M; Lindsley, R Coleman; Hantel, Andrew

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

对于预后不良的MDS/AML患者,先进行Venetoclax/FluBu2 RIC移植,随后进行全口服Venetoclax/地西他滨维持治疗。

Garcia, Jacqueline S; Kim, Haesook T; Murdock, H Moses; Bosch-Vilaseca, Anna; Panaro, Kevin M; Lim, Felicia; Fiorilla, Jade; Auriemma, Elise; Brock, Jennifer; Gooptu, Mahasweta; Ho, Vincent T; Cutler, Corey S; Shapiro, Roman; Kelkar, Amar H; Abel, Gregory A; DeAngelo, Daniel J; Stone, Richard M; Bat-Erdene, Denbaa; Ryan, Jeremy; Fell, Geoffrey; Letai, Anthony; Ritz, Jerome; Lindsley, R Coleman; Antin, Joseph H; Soiffer, Robert J

Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia

急性髓系白血病中PTPN11突变的克隆层级和免疫表型特征分析

Fobare, Sydney; Sharpe, Chia; Quinn, Kate; Bryant, Kinsey; Miles, Linde A; Bowman, Robert L; Cheney, Carolyn; Furby, Casie; Long, Marissa; Fyock, Kaytlynn; Wronowski, Ben; Lerma, James R; Mrózek, Krzysztof; Nicolet, Deedra; Sesterhenn, Thomas M; Johnstone, Megan E; Pan, Jianmin; Rai, Shesh N; Pasare, Chandrashekhar; Zimmermann, Nives; Yu, Wen-Mei; Qu, Cheng-Kui; Carroll, Andrew; Stone, Richard; Wang, Eunice S; Kolitz, Jonathan; Powell, Bayard; Perentesis, John P; Eisfeld, Ann-Kathrin; Hertlein, Erin; Byrd, John C

Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics

HMA联合维奈托克与强化化疗治疗极高危细胞遗传学AML的疗效比较

Aguirre, Luis E; Bewersdorf, Jan Philipp; Liu, Yiwen; Shallis, Rory M; Boussi, Leora; Zucenka, Andrius; Garciaz, Sylvain; Bystrom, Rebecca P; DeAngelo, Daniel J; Stone, Richard M; Luskin, Marlise R; Garcia, Jacqueline S; Winer, Eric S; Ling, Kelly; Chen, Evan C; Wadleigh, Martha; Berton, Guillaume; Stein, Eytan M; Goldberg, Aaron D; Mendez, Lourdes; Zeidan, Amer M; Sallman, David A; Shimony, Shai; Stahl, Maximilian

Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia

协同靶向 eIF4A 介导的翻译起始和急性髓系白血病中的细胞凋亡

Lee, Yoke Seng; Good, Jonathan D; Awais, Noha; Eschle, Benjamin K; Lineberry, Maia S; Lin, Jingting; Wunderlich, Mark; Thibodeau, Jenna; Edwards, Holly; Teo, Jessica L; Bibeau, Sarah; Wollman, Morgan; Karadimov, George; Sariipek, Nurefsan; Salik, Basit; Acosta, Jean; Noel, Jenny; Cucchi, David G J; DePasquale, Erica A K; Gokhale, Prafulla C; Ritz, Jerome; Ge, Yubin; Miller, Peter G; Najm, Fadi J; Stone, Richard M; Garcia, Jacqueline S; Lane, Andrew A; Jones, Courtney L; van Galen, Peter

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results

伊诺妥珠单抗、奥佐米星联合布林妥莫单抗治疗新诊断的老年B细胞急性淋巴细胞白血病患者:A041703联盟研究队列1结果

Wieduwilt, Matthew J; Yin, Jun; Kour, Oudom; Teske, Rebecca; Stock, Wendy; Escherich, Carolin; Yang, Jun; Li, Zhenhua; Byrd, Kenneth; Doucette, Kimberley; Mangan, James; Hall, Scott; Mims, Alice S; Jamieson, Katarzyna; Dinner, Shira N; Bseiso, Ali W; Giordano, Giorgia; Saygin, Caner; Uy, Geoffrey L; Litzow, Mark R; Stone, Richard M

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M